Wellington Management Group LLP Vaxcyte, Inc. Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 6,416,930 shares of PCVX stock, worth $203 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,416,930

Holding current value

$203 Million

% of portfolio

0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$37.76 - $92.13 $242 Million - $591 Million	6,416,930 New	6,416,930 $242 Million
Q4 2024 Feb 12, 2025	SELL	$80.97 - $117.93 $5.65 Million - $8.22 Million	-69,744 Reduced 1.55%	4,444,012 $364 Million
Q3 2024 Nov 14, 2024	SELL	$70.52 - $117.12 $5.59 Million - $9.29 Million	-79,310 Reduced 1.73%	4,513,756 $515 Million
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $19.6 Million - $25.7 Million	-326,304 Reduced 6.63%	4,593,066 $347 Million
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $294 Million - $399 Million	4,919,370 New	4,919,370 $336 Million
Q4 2023 Feb 12, 2024	BUY	$45.35 - $63.41 $201 Million - $281 Million	4,431,920 New	4,431,920 $278 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $7.71 Million - $8.89 Million	167,501 Added 3.78%	4,598,712 $234 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $41.3 Million - $64.4 Million	1,191,937 Added 36.8%	4,431,211 $221 Million
Q1 2023 May 12, 2023	SELL	$36.27 - $47.2 $10.5 Million - $13.6 Million	-288,840 Reduced 8.19%	3,239,274 $121 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $36.6 Million - $85.3 Million	1,779,193 Added 101.73%	3,528,114 $169 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $35.1 Million - $46.2 Million	1,619,700 Added 1253.43%	1,748,921 $42 Million
Q2 2022 Aug 15, 2022	SELL	$17.68 - $26.58 $18 Million - $27 Million	-1,015,594 Reduced 88.71%	129,221 $2.81 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $143,346 - $216,415	-8,210 Reduced 0.71%	1,144,815 $27.6 Million
Q4 2021 Feb 11, 2022	BUY	$19.32 - $26.45 $2.22 Million - $3.04 Million	114,804 Added 11.06%	1,153,025 $27.4 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $3.24 Million - $4.32 Million	160,096 Added 18.23%	1,038,221 $26.3 Million
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $1.98 Million - $2.89 Million	-120,285 Reduced 12.05%	878,125 $19.8 Million
Q1 2021 May 17, 2021	SELL	$18.66 - $29.16 $232,130 - $362,750	-12,440 Reduced 1.23%	998,410 $19.7 Million
Q4 2020 Feb 12, 2021	SELL	$26.57 - $51.74 $2.31 Million - $4.5 Million	-87,006 Reduced 7.93%	1,010,850 $26.9 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $2.71 Million - $5.66 Million	-102,144 Reduced 8.51%	1,097,856 $54.2 Million
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $31.4 Million - $42.5 Million	1,200,000 New	1,200,000 $37.9 Million

Others Institutions Holding PCVX

# of Institutions

348

Shares Held

131M

Call Options Held

527K

Put Options Held

241K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $1.87B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Vaxcyte, Inc. Transaction History